Lancet Aug 2014,. DOI: http://dx.doi.org/10.1016/S1473-3099(14)70780-7
Thomas P Van Boeckel, PhD, Sumanth Gandra, MD, Ashvin Ashok, MPP, Quentin Caudron, PhD, Prof Bryan T Grenfell, PhD, Prof Simon A Levin, PhD, Prof Ramanan Laxminarayan
This is not the decrease use needed to avoid the creation of superbugs
- Antibiotics to increase weight of farm animals is far larger than human use
- Huge recent increase of antibiotics in Australia
– Australia has seen a huge recent increase in autism (due to antibitocs?)
See also VitaminDWiki
- Off Topic: 200,000 deaths annually due to superbugs - 10,000,000 annually in 35 years – Dec 2014
- Overview Autism and vitamin D
Notice how autism has increased in Australia
The TOP articles in Antibiotics, probiotics and Vitamin D are listed here:
- Reasons for Low Vitamin D and what to do
- Fecal transplants increased Vitamin D levels (germ-free mice) – March 2018
- Vitamin D treatment of diabetes (50,000 IU every 2 weeks) augmented by probiotic – RCT June 2018
- Autism risk increased if infant had antibiotics (2X), acetaminophen (3X), or no vitamin D drops (1.5X) – June 2018
- Child Asthma increased 2.1 X by antibiotics, Child milk allergy increased 4.4 X by PPI – April 2018
- Gut microbiome massively changed by high dose vitamin D – July 2015
- Huge increases in health problems – risk factors include Vitamin D, Antibiotics, and Roundup
- Low-level antibiotics causes weight gain in mice (and most mammals) – Aug 2014
- Antibiotics and Vitamin D are associated with many of the same diseases
- Antibiotic use cut in half by elderly (over 70) after monthly 60,000 IU of vitamin D – RCT Dec 2013
- Soft Bones, Hard Arteries, Vitamin D, Vitamin K2 and antibiotics – Sept 2012
- Reasons for low response to vitamin D
Antibiotic drug consumption is a major driver of antibiotic resistance. Variations in antibiotic resistance across countries are attributable, in part, to different volumes and patterns for antibiotic consumption. We aimed to assess variations in consumption to assist monitoring of the rise of resistance and development of rational-use policies and to provide a baseline for future assessment.
With use of sales data for retail and hospital pharmacies from the IMS Health MIDAS database, we reviewed trends for consumption of standard units of antibiotics between 2000 and 2010 for 71 countries. We used compound annual growth rates to assess temporal differences in consumption for each country and Fourier series and regression methods to assess seasonal differences in consumption in 63 of the countries.
Between 2000 and 2010, consumption of antibiotic drugs increased by 36% (from 54 083 964 813 standard units to 73 620 748 816 standard units). Brazil, Russia, India, China, and South Africa accounted for 76% of this increase. In most countries, antibiotic consumption varied significantly with season. There was increased consumption of carbapenems (45%) and polymixins (13%), two last-resort classes of antibiotic drugs.
The rise of antibiotic consumption and the increase in use of last-resort antibiotic drugs raises serious concerns for public health. Appropriate use of antibiotics in developing countries should be encouraged. However, to prevent a striking rise in resistance in low-income and middle-income countries with large populations and to preserve antibiotic efficacy worldwide, programmes that promote rational use through coordinated efforts by the international community should be a priority.
US Department of Homeland Security, Bill & Melinda Gates Foundation, US National Institutes of Health, Princeton Grand Challenges Program.
Download the PDF from VitaminDWiki.